Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer

DJ Vaughn; J Bellmunt; Y Fradet; JL Lee; L Fong; NJ Vogelzang; MA Climent; DP Petrylak; TK Choueiri; A Necchi; W Gerritsen; H Gurney; DI Quinn; S Culine; CN Sternberg; YB Mai; HJ Li; RF Perini; DF Bajorin; Ronald de Wit

doi:10.1200/jco.2017.76.9562

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer

DJ Vaughn, J Bellmunt, Y Fradet, JL Lee, L Fong, NJ Vogelzang, MA Climent, DP Petrylak, TK Choueiri, A Necchi, W Gerritsen, H Gurney, DI Quinn, S Culine, CN Sternberg, YB Mai, HJ Li, RF Perini, DF Bajorin, Ronald de Wit

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

101 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1579-1587
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	36
Issue number	16
DOIs	https://doi.org/10.1200/jco.2017.76.9562
Publication status	Published - 2018

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2017.76.9562

http://hdl.handle.net/1765/113166

Cite this

Vaughn, DJ., Bellmunt, J., Fradet, Y., Lee, JL., Fong, L., Vogelzang, NJ., Climent, MA., Petrylak, DP., Choueiri, TK., Necchi, A., Gerritsen, W., Gurney, H., Quinn, DI., Culine, S., Sternberg, CN., Mai, YB., Li, HJ., Perini, RF., Bajorin, DF., & de Wit, R. (2018). Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer. Journal of Clinical Oncology, 36(16), 1579-1587. https://doi.org/10.1200/jco.2017.76.9562

@article{15f1b30b5eb6435ab5e50c24ab860dd2,

title = "Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer",

author = "DJ Vaughn and J Bellmunt and Y Fradet and JL Lee and L Fong and NJ Vogelzang and MA Climent and DP Petrylak and TK Choueiri and A Necchi and W Gerritsen and H Gurney and DI Quinn and S Culine and CN Sternberg and YB Mai and HJ Li and RF Perini and DF Bajorin and \{de Wit\}, Ronald",

year = "2018",

doi = "10.1200/jco.2017.76.9562",

language = "Undefined/Unknown",

volume = "36",

pages = "1579--1587",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "16",

}

Vaughn, DJ, Bellmunt, J, Fradet, Y, Lee, JL, Fong, L, Vogelzang, NJ, Climent, MA, Petrylak, DP, Choueiri, TK, Necchi, A, Gerritsen, W, Gurney, H, Quinn, DI, Culine, S, Sternberg, CN, Mai, YB, Li, HJ, Perini, RF, Bajorin, DF & de Wit, R 2018, 'Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer', Journal of Clinical Oncology, vol. 36, no. 16, pp. 1579-1587. https://doi.org/10.1200/jco.2017.76.9562

TY - JOUR

T1 - Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer

AU - Vaughn, DJ

AU - Bellmunt, J

AU - Fradet, Y

AU - Lee, JL

AU - Fong, L

AU - Vogelzang, NJ

AU - Climent, MA

AU - Petrylak, DP

AU - Choueiri, TK

AU - Necchi, A

AU - Gerritsen, W

AU - Gurney, H

AU - Quinn, DI

AU - Culine, S

AU - Sternberg, CN

AU - Mai, YB

AU - Li, HJ

AU - Perini, RF

AU - Bajorin, DF

AU - de Wit, Ronald

PY - 2018

Y1 - 2018

U2 - 10.1200/jco.2017.76.9562

DO - 10.1200/jco.2017.76.9562

M3 - Article

SN - 0732-183X

VL - 36

SP - 1579

EP - 1587

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -